U.S. SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

                                FORM 24F-2
                     Annual Notice of Securities Sold
                          Pursuant to Rule 24f-2 


1.   Name and address of issuer: 

          Oppenheimer Series Fund, Inc.
          Two World Trade Center
          New York, NY 10048-0203

2.   Name of each series or class of funds for which this notice is
     filed: 

          Oppenheimer LifeSpan Growth Fund, Class C

3.   Investment Company Act File Number: 811-3346

     Securities Act File Number: 2-75276

4.   Last day of fiscal year for which this notice is filed:
     10/31/96

5.   Check box if this notice is being filed more than 180 days
     after the close of the issuer's fiscal year for purposes of
     reporting securities sold after the close of the fiscal year
     but before termination of the issuer's 24f-2 declaration:
                                                                       /  /

6.   Date of termination of issuer's declaration under rule 24f-
     2(a)(1), if applicable (see instruction a.6):

7.   Number and amount of securities of the same class or series
     which had been registered under the Securities Act of 1933
     other than pursuant to rule 24f-2 in a prior fiscal year, but
     which remained unsold at the beginning of the fiscal year: -0-

8.   Number and amount of securities registered during the fiscal
     year other than pursuant to rule 24f-2:  -0-

9.   Number and aggregate sale price of securities sold during the
     fiscal year:   

          11,124          $138,640

10.  Number and aggregate sale price of securities sold during the
     fiscal year in reliance upon registration pursuant to rule
     24f-2:

          11,124          $138,640

11.  Number and aggregate sale price of securities issued during
     the fiscal year in connection with dividend reinvestment
     plans, if applicable (see Instruction B.7): 

          16              $198

12.  Calculation of registration fee:

     (i)   Aggregate sale price of securities sold 
           during the fiscal year in reliance on 
           rule 24f-2 (from Item 10):               $138,640
                                                    ------------
     (ii)  Aggregate price of shares issued in 
           connection with dividend reinvestment 
           plans (from Item 11, if applicable):     +$198
                                                    ------------
     (iii) Aggregate price of shares redeemed or 
           repurchased during the fiscal year 
           (if applicable):                         -$978
                                                    ------------
     (iv)  Aggregate price of shares redeemed or 
           repurchased and previously applied as 
           a reduction to filing fees pursuant to 
           rule 24e-2 (if applicable):              +  -0-
                                                    ------------
     (v)   Net aggregate price of securities sold 
           and issued during the fiscal year in 
           reliance on rule 24f-2 (line (i), plus 
           line (ii), less line (iii), plus line 
           (iv)) (if applicable):                   $137,860
                                                    ------------
     (vi)  Multiplier prescribed by Section 6(b) 
           of the Securities Act of 1933 or other 
           applicable law or regulation (see 
           Instruction C.6):                        x 1/3300
                                                    ------------
     (vii) Fee due (line (i) or line (v) multiplied 
           by line (vi)):                           $42
                                                    ------------

Instruction: Issuers should complete line (ii), (iii), (iv), and
             (v) only if the form is being filed within 60 days
             after the close of the issuer's fiscal year.  See
             Instructions C.3.

13.  Check box if fees are being remitted to the Commission's
     lockbox depository as described in section 3a of the
     Commission's Rule of Informal and Other Procedures (17 CFR
     202.3a).                                                           /X/

     Date of mailing or wire transfer of filing fees to the
     Commission's lockbox depository: 

             December 19, 1996; Fed Wire #3340


                                SIGNATURES

This report has been signed below by the following persons on
behalf of the issuer and in the capacities and on the dates
indicated.

                    Oppenheimer Series Fund, Inc.



                    By: /s/ Robert J. Bishop
                       -------------------------------------
                       Robert J. Bishop, Assistant Treasurer

Date: 12/23/96


cc:  Ronald Feiman, Esq.
     Katherine Feld
     Gloria LaFond


sec\ser335c.24f


               GORDON ALTMAN BUTOWSKY WEITZEN SHALOV & WEIN
114 West 47th Street                                   New York, N.Y. 10036
Telephone: (212) 626-0800                         Telecopier (212) 626-0799





                              December 20, 1996



Oppenheimer Series Fund, Inc.
Two World Trade Center
New York, New York 10048

Ladies and Gentlemen:

          In connection with the public offering of Class C shares
of beneficial interest, no par value (the "Shares") of Oppenheimer
LifeSpan Growth Fund, a series of the Oppenheimer Series Fund, Inc.
(the "Fund"), we have examined such records and documents and have
made such further investigation and examination as we deemed
necessary for the purpose of this opinion.

          It is our opinion that the Shares, the registration of
which is made definite by the accompanying Rule 24f-2 Notice of the
Fund, were legally issued, fully paid and non-assessable by the
Fund to the extent set forth in its Prospectus forming part of its
Registration Statement under the Securities Act of 1933, as
amended.

          We hereby consent to the filing of this opinion with said
Notice.


                              Very truly yours,

                              /s/GORDON ALTMAN BUTOWSKY
                                 WEITZEN SHALOV & WEIN